BREAKING NEWS

BREAKING NEWS

Drugmaker Vectura's first half revenue up 6 percent on rising sales of inhaled products

Now Reading:

Drugmaker Vectura's first half revenue up 6 percent on rising sales of inhaled products

Text size Aa Aa

Vectura <VEC.L> said revenue rose 6 percent in the first half of the year, driven by rising sales of its recently launched inhaled products and the continued weakness of sterling against a basket of its main trading currencies. The FTSE-250 firm that specializes in developing lung drugs said revenue rose to 78.8 million pounds ($102.67 million) in the six months ended June 30 from 73.9 million pounds in the prior-year period. The company posted a higher loss before tax of 44.5 million pounds, up from a loss of 22.4 million pounds earlier, as amortisation expenses continued to increase following its merger with SkyePharma in June.

(Reporting by Justin George Varghese in Bengaluru, editing by Louise Heavens)
euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.